Lack of pharmacokinetic interaction between valproic acid and a traditional Chinese medicine, Paeoniae Radix, in healthy volunteers

被引:19
作者
Chen, LC
Chou, MH
Lin, MF
Yang, LL
机构
[1] Natl Chiayi Univ, Life Sci Coll, Dean Off, Grad Inst Biotechnol, Chiayi 600, Taiwan
[2] Taipei Med Coll, Grad Inst Pharmaceut Sci, Dept Pharmacognosy, Taipei, Taiwan
[3] Vet Gen Hosp, Dept Pharm, Taipei, Taiwan
关键词
Chinese medicine; Paeoniae Radix; valproic acid;
D O I
10.1046/j.1365-2710.2000.00313.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and objective: In addition to the standard antiepileptic drugs, traditional Chinese medicines (TCMs) are used for the treatment of epilepsy in oriental countries. The interactions between antiepileptic drugs and TCMs represent a potential problem in clinical application. Because valproic acid (VPA), one of the most widely prescribed antiepileptic drugs, may be administered concomitantly with Paeoniae Radix (PR), one of the famous TCMs, in some epileptic patients, the present study was conducted to evaluate the influences of PR on the pharmacokinetics of VPA. Method: The pharmacokinetics of VPA were investigated in a randomized, open-label, two-way crossover study, Six healthy volunteers received the following treatments in a crossover design: (i) 1.2 g extract powder of Paeoniae Radix once daily for 7 days and one 200 mg VPA gastro-resistant tablet on day 7 and (ii) one 200 mg VPA gastro-resistant tablet alone on day 7. Serial plasma samples were obtained on day 7. Total and free (unbound) VPA plasma concentrations were determined by fluorescence polarization immunoassay (FPIA). Safety measures included laboratory tests (haematology, serum chemistry and urinalysis) and adverse event monitoring. Statistical comparisons of pharmacokinetic parameters were performed with the Student paired t-test. Results: Overall clinical safety was satisfactory. The mean maximum plasma concentration of VPA was attained at within 6 h after oral administration of VPA alone and 3-4 h after oral administration of VPA in combination with PR. The plasma level of VPA declined with a half-life of 11.71 and 11.91 h, respectively. No statistically significant difference was obtained in any of the pharmacokinetic parameters (T-max, C-max, AUC, t(1/2), MRT, CL/F and V-d/F) of VPA between the two treatments. Also, there was no significant difference in the protein binding rates of VPA. Conclusion: PR did not significantly affect the absorption, distribution, metabolism and elimination of VPA in healthy volunteers.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 40 条
  • [1] Abdel-Hafez AA, 1999, BIOL PHARM BULL, V22, P491, DOI 10.1248/bpb.22.491
  • [2] Abdel-Hafez AA, 1998, CHEM PHARM BULL, V46, P1486
  • [3] A mechanistic approach to antiepileptic drug interactions
    Anderson, GD
    [J]. ANNALS OF PHARMACOTHERAPY, 1998, 32 (05) : 554 - 563
  • [4] [Anonymous], JPN J PHARM S
  • [5] VALPROIC ACID DOSAGE AND PLASMA-PROTEIN BINDING AND CLEARANCE
    BOWDLE, TA
    PATEL, IH
    LEVY, RH
    WILENSKY, AJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (04) : 486 - 492
  • [6] BRODIE MJ, 1992, EPILEPSIA S1, V33, P13
  • [7] PROTEIN-BINDING OF VALPROIC ACID IN UREMIC PATIENTS
    BRUNI, J
    WANG, LH
    MARBURY, TC
    LEE, CS
    WILDER, BJ
    [J]. NEUROLOGY, 1980, 30 (05) : 557 - 559
  • [8] Chen LC, 2000, J CLIN PHARM THER, V25, P125, DOI 10.1046/j.1365-2710.2000.00271.x
  • [9] COMPLEMENTARY EFFECTS OF PAEONIFLORIN AND GLYCYRRHIZIN ON INTRACELLULAR CA2+ MOBILIZATION IN THE NERVE-STIMULATED SKELETAL-MUSCLE OF MICE
    DEZAKI, K
    KIMURA, I
    MIYAHARA, K
    KIMURA, M
    [J]. JAPANESE JOURNAL OF PHARMACOLOGY, 1995, 69 (03) : 281 - 284
  • [10] UNCONVENTIONAL MEDICINE IN THE UNITED-STATES - PREVALENCE, COSTS, AND PATTERNS OF USE
    EISENBERG, DM
    KESSLER, RC
    FOSTER, C
    NORLOCK, FE
    CALKINS, DR
    DELBANCO, TL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) : 246 - 252